<DOC>
	<DOC>NCT00386659</DOC>
	<brief_summary>Pilot, randomized, parallel, open-label, controlled, clinical study evaluating virological response in plasma and extra-plasmatic compartments, together with the degree and kinetics of immune reconstitution in treatment-naïve patients with CD4 count below 100 cells/mL, when treated with tenofovir and abacavir together with lopinavir or efavirenz.</brief_summary>
	<brief_title>Immune Reconstitution in naïve HIV Patients With CD4 &lt;100 Cells/mL When Treated With Lopinavir or Efavirenz.</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<criteria>HIVinfection Antiretroviralnaive CD4 cell count below 100 cells/mm3 Pregnancy Current opportunistic infection requiring parenteral therapy Current malignancies requiring parenteral chemotherapy Any contraindication to the study drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>